indication

Healthy

Competitive landscape projected to PF-06412562 TBD mg’s launch window

as of 2026-07-01
Competitive set
2
1 approved · 1 pipeline

Projection timeline

actual past → guided future · protection walls overlaid
12 events
2020
2024
2028
2032
2036
2040
2044
2048
today
PF-06412562 TBD mg launch window
guided / estimated ↑
actual ↓
focal / guidedapprovallabel expansiontrial readoutcongressnclustered events (click to expand)guided (dashed = directional)competitor patent cliff

Competitive set

resolved drugs with trials in this indication
drugCompleted
Ziprasidone
US-approved 2001 · Geodon
Phase 11 trial
OwnerPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Protection—
drugCompleted
Cannabidiol
Pipeline · Early Phase 1
Early Phase 11 trial
OwnerCentral Institute of Mental Health, Mannheim
Protection—

Market size

prevalence as a range, not a number